US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 8.150
  • -0.280-3.32%
Close Oct 31 16:00 ET
  • 8.150
  • 0.0000.00%
Post 20:01 ET
428.83MMarket Cap-4766P/E (TTM)

Zevra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zevra Therapeutics Q3 2024 Estimates Date

Currency：USDNov 12, 2024

Estimate YoY
Revenue
4.86M
+67.97%
EPS
-0.42
-5.33%
Analyst Rating
Strong Buy

Oct 31, 2024

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 10.649M--
Nov 12, 20242024/Q3-- / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 10.649M--
Nov 12, 20242024/Q3-- / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--
Mar 28, 20242023/Q413.217M / 11.738M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 14:30 ET

  • 10-Q: Q1 2024 Earnings Report

    May 9 16:38 ET

  • Zevra Therapeutics | 10-K: FY2023 Annual Report

    Apr 1 17:33 ET

  • Zevra Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 17:23 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data